Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Neuropathic Pain Article
![]()
This is a selection made from among articles on Drug Treatment Neuropathic Pain. For a permanent link to this article, or to bookmark it for future reading, click here.
Illegal and Legal Drug Usage in the United States
from:by Lance Winslow
How bad is the illegal drug problem here in the US? Very bad and it alters the brain’s thought process and causes a problem with human interaction and our natural socializing tendencies. The drugs are so diverse and so plentiful that it touches the lives of nearly every American in some way and certainly nearly every family in this country. We must be honest with ourselves. We have legal drugs, prescription drugs and illegal drugs. Caffeine is a drug that is wide spread in America. The verdict is out now, but what will we learn in the future after twenty years? After all there is a Starbucks on nearly every corner in many of America’s largest metropolitan areas. We already know that spiders cannot spin a web while under influence of caffeine.What is Caffeine content in your life? Ask for yourself, look in that mirror and then take a look at the world around you. No wonder people cut you off in traffic, they are in a mad tear to where? In front of you so they can hurry up and wait. Now it appears that kids are using caffeine to get high? In combination with other drugs; think about this. The “pick me up” that most Americans use to get through the day, wake up in the mourning is penetrating other parts of society. Why? Why would this happen? Well here are some interesting stories of kids using caffeine to get a rush.http://www.twilightbridge.com/deaddictions/coffee.htmhttp://www.ecureme.com/emyhealth/natural/n_caffeine.asp .There is much more on Blogs across the Internet, “google” it sometime and see what you come up with. We have kids taking crystal meth and killing their bodies and becoming very horrible workers as far a responsibility and work ethic go, and when they cannot keep a job and have no money to buy drugs they are trying to duplicate some sort of experience using caffeine. Wow, this is a problem really. Think of all the mood altering drugs being used Prozac one-way, caffeine the other, and all the illegal stuff in between. How is the human brain suppose to operate efficiently and develop normally with all this foreign content and the extreme ratios? Maybe some people ought to figure out a way to reduce this desire for mood enhancement?There is much information on the Internet about this and perhaps we, as a society should be doing something to help people think about what they are doing to themselves? And to find a reason to live life to it’s fullest without a mood enhancements.http://healthcenter.ucdavis.edu/htcaffeine.htmlSo if we are to have caffeine as a way of life we ought to let people know that the caffeine buzz that kids are trying to get from using it is not all that great.http://www.ceida.net.au/tools_for_workers/...s/caffeine.htmlNow this maybe a better stimulate over all to other drugs, but no drugs is the better solution. It would be better for the productivity of America, better for kids and better for long-term health. Think about it.
Drug Treatment Neuropathic Pain Specific links
Drug Treatment Neuropathic Pain News
New study finds treatment for neuropathic pain - allvoices
New study finds treatment for neuropathic pain allvoices "Now we are working toward the possibility of potential treatments that might eliminate the source of neuropathic pain, and that may be much more effective than drugs that aim only to treat symptomatically the pain that results from chronic, ... Stem Cell Transplants Treat Chronic Pain |
Cell therapy may ease chronic pain - Pakistan Observer
Cell therapy may ease chronic pain Pakistan Observer “Now we are working toward the possibility of potential treatments that might eliminate the source of neuropathic pain, and that may be much more effective than drugs that aim only to treat symptomatically the pain that results from chronic, ... |
Stem Cells Curb Chronic Pain in Mice - ABC News (blog)
![]() eMaxHealth | Stem Cells Curb Chronic Pain in Mice ABC News (blog) “The clinical significance is that we think we're actually modifying the disease, not just treating the symptoms,” Basbaum said, adding that drugs currently used to ease neuropathic pain fail to treat the underlying problem. “Instead of taking a drug ... Cell Transplantation Could Relieve Chronic Pain UCSF Study Uses Cell Transplant Therapy to Reduce Neuropathic Pain Cell Transplant Tested as Treatment for Nerve Pain in Mice |
DARA BioSciences Paves Foundation for Growth - Equities.com
DARA BioSciences Paves Foundation for Growth Equities.com In its pipeline, DARA is also in Phase 2 development of KRN5500, a treatment of neuropathic pain for patients with cancer. The drug candidate has received the Fast Track Designation by the Food and Drug Administration, and a recent external data ... |
Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to ... - MarketWatch (press release)
Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to ... MarketWatch (press release) The report analyzes current method of practice for various indications including post-operative pain management, osteoarthritis, cancer pain, neuropathic pain and lower back pain. Treatment flow, prescription share, driver and restraints have been ... |
Pfizer's Lyrica Fails In Inadequately Treated PDPN; Trial For New Use Halted - NASDAQ
![]() Fox11online.com | Pfizer's Lyrica Fails In Inadequately Treated PDPN; Trial For New Use Halted NASDAQ (RTTNews.com) - Pfizer Inc. (PFE) said Friday a late stage study of its neuropathic pain drug Lyrica failed to meet its primary point in patients with inadequately treated painful diabetic peripheral neuropathy, or pDPN - a form of nerve damage mainly ... Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic ... Pfizer Axes Late-Stage Lyrica Study Following Disappointing Results Pfizer's Lyrica Nerve-Pain Drug Fails To Meet Endpoint In Diabetes Study |
DARA BioSciences Announces New Analysis of Patient Self-Reported Diary Results ... - MarketWatch (press release)
DARA BioSciences Announces New Analysis of Patient Self-Reported Diary Results ... MarketWatch (press release) RALEIGH, NC, May 9, 2012 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (UTD:DARA) (the "Company" or "DARA") announced today that it will advance development of its novel Phase 2 drug candidate for the treatment of neuropathic pain in patients with cancer. DARA BioSciences To Advance Development Of Novel Phase 2 Drug Candidate |
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... - MarketWatch (press release)
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... MarketWatch (press release) Over time, people with diabetes can develop a type of nerve damage called neuropathy. Approximately 60 to 70 percent of people with diabetes have some form of neuropathy(3). The most common type is diabetic peripheral neuropathy, which causes pain or ... |
Pregabalin Fails to Improve Diabetic, HIV Neuropathy - Medscape
![]() EON: Enhanced Online News (press release) | Pregabalin Fails to Improve Diabetic, HIV Neuropathy Medscape May 8, 2012 — A phase 3 clinical trial of pregabalin (Lyrica, Pfizer) failed to meet its primary endpoint of improvement in mean pain scores relative to baseline in patients with inadequately treated painful diabetic neuropathy, the company announced. Pfizer Drug Lyrica Fails in Phase 3 Study In Patients With Diabetic Peripheral ... Lyrica Fails in Pain Trials Pfizer halts late-stage study into possible additional use for pain treatment ... |
Pregabalin Treats Neuropathic Pain in Spinal Cord Injury - Medscape
Pregabalin Treats Neuropathic Pain in Spinal Cord Injury Medscape Pregabalin is already approved in the United States for the management of fibromyalgia, neuropathic pain associated with diabetic peripheral neuropathy, and for postherpetic neuralgia. It is also approved for adjunctive therapy for adult patients with ... |




